KAKKIS EMIL D bought RARE
March 1, 2026 · Form 4 insider transaction
KAKKIS EMIL D bought 71,177 shares of Ultragenyx Pharmaceutical Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
71,177
Price
$0.00
Total value
N/A
InsiderKAKKIS EMIL D
RoleOfficer, Director
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMarch 1, 2026
Filing dateMarch 3, 2026
Shares owned after712,908
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares of common stock which previously granted performance stock units were converted on March 1, 2026 upon certification of the performance metrics.